Ocular Therapeutix
OCUL
OCUL
150 hedge funds and large institutions have $940M invested in Ocular Therapeutix in 2024 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 55 increasing their positions, 27 reducing their positions, and 36 closing their positions.
Holders
150
Holders Change
+2
Holders Change %
+1.35%
% of All Funds
2.18%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.1%
New
39
Increased
55
Reduced
27
Closed
36
Calls
$1.63M
Puts
$3.72M
Net Calls
-$2.09M
Net Calls Change
+$9.34M
Top Buyers
1 |
1
BlackRock
New York
|
$78.8M |
2 |
![]()
2
Adage Capital Partners
Boston,
Massachusetts
|
$25.3M |
3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$18.5M |
4 |
B
4
Braidwell
Stamford,
Connecticut
|
$11.2M |
5 |
5
State Street
Boston,
Massachusetts
|
$26.8M |